Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Falk

Showing results (381-390 of 421) with videos related to

Pageof 43
Sort By:
Journal of Cellular Physiology|September 1, 1996
Involvement of CD44 and the cytoskeletal linker protein ankyrin in human neutrophil bacterial phagocytosisF L Moffat, T Han, Z M Li, et al.
Journal of Clinical Psychopharmacology|June 1, 1989
Anticholinergic effects on memory: benztropine versus amantadineA J Gelenberg, T Van Putten, P W Lavori, et al.
Nucleic Acids Research|November 10, 2010
Targeted resequencing of candidate genes using selector probesH Johansson, M Isaksson, E Falk Sörqvist, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|January 1, 1982
Intermittent percutaneous infusion into the hepatic artery of cytotoxic drugs for hepatic tumoursR E Falk, P Greig, L Makowka, et al.
American Journal of Human Genetics|March 1, 1990
Linkage of an autosomal dominant clefting syndrome (Van der Woude) to loci on chromosome IqJ C Murray, D Y Nishimura, K H Buetow, et al.
Alcohol, Clinical & Experimental Research|December 3, 2024
Effects of a novel GABA-B positive allosteric modulator, ASP8062, on alcohol cue-elicited craving and naturalistic alcohol consumption in a multisite randomized, double-blind, placebo-controlled trialJoseph P Schacht, Lara A Ray, Robert Miranda, et al.
Alcoholism, Clinical and Experimental Research|March 16, 2017
Temporal Stability of Heavy Drinking Days and Drinking Reductions Among Heavy Drinkers in the COMBINE StudyKatie Witkiewitz, Adam D Wilson, Matthew R Pearson, et al.
JAMA Psychiatry|March 14, 2019
Evaluation of Drinking Risk Levels as Outcomes in Alcohol Pharmacotherapy Trials: A Secondary Analysis of 3 Randomized Clinical TrialsDaniel E Falk, Stephanie S O'Malley, Katie Witkiewitz, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 9, 2011
The Alcohol Clinical Trials Initiative (ACTIVE): purpose and goals for assessing important and salient issues for medications development in alcohol use disordersRaymond F Anton, Raye Z Litten, Daniel E Falk, et al.
Clinical Genetics|February 6, 2013
Deletion of MAP2K2/MEK2: a novel mechanism for a RASopathy?M J M Nowaczyk, B A Thompson, S Zeesman, et al.
Pageof 43

Showing results (381-390 of 421) with videos related to

Sort By:
Pageof 43
Journal of Cellular Physiology|September 1, 1996
Involvement of CD44 and the cytoskeletal linker protein ankyrin in human neutrophil bacterial phagocytosisF L Moffat, T Han, Z M Li, et al.
Journal of Clinical Psychopharmacology|June 1, 1989
Anticholinergic effects on memory: benztropine versus amantadineA J Gelenberg, T Van Putten, P W Lavori, et al.
Nucleic Acids Research|November 10, 2010
Targeted resequencing of candidate genes using selector probesH Johansson, M Isaksson, E Falk Sörqvist, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|January 1, 1982
Intermittent percutaneous infusion into the hepatic artery of cytotoxic drugs for hepatic tumoursR E Falk, P Greig, L Makowka, et al.
American Journal of Human Genetics|March 1, 1990
Linkage of an autosomal dominant clefting syndrome (Van der Woude) to loci on chromosome IqJ C Murray, D Y Nishimura, K H Buetow, et al.
Alcohol, Clinical & Experimental Research|December 3, 2024
Effects of a novel GABA-B positive allosteric modulator, ASP8062, on alcohol cue-elicited craving and naturalistic alcohol consumption in a multisite randomized, double-blind, placebo-controlled trialJoseph P Schacht, Lara A Ray, Robert Miranda, et al.
Alcoholism, Clinical and Experimental Research|March 16, 2017
Temporal Stability of Heavy Drinking Days and Drinking Reductions Among Heavy Drinkers in the COMBINE StudyKatie Witkiewitz, Adam D Wilson, Matthew R Pearson, et al.
JAMA Psychiatry|March 14, 2019
Evaluation of Drinking Risk Levels as Outcomes in Alcohol Pharmacotherapy Trials: A Secondary Analysis of 3 Randomized Clinical TrialsDaniel E Falk, Stephanie S O'Malley, Katie Witkiewitz, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 9, 2011
The Alcohol Clinical Trials Initiative (ACTIVE): purpose and goals for assessing important and salient issues for medications development in alcohol use disordersRaymond F Anton, Raye Z Litten, Daniel E Falk, et al.
Clinical Genetics|February 6, 2013
Deletion of MAP2K2/MEK2: a novel mechanism for a RASopathy?M J M Nowaczyk, B A Thompson, S Zeesman, et al.
Pageof 43